Healthcare startup Medial EarlySign – based in Israel – raises $30 million. The technology is meant to help improve patient management Reuters claims.
The technology of Medial EarlySign can be used to existing blood test results and electronic health records to provide insights to healthcare organizations as they determine the best approach to improving patients’ health.
Ori Geva, CEO of Medial EarlySign, said the funding will be used to broaden the company’s solutions and expand clinical research and global implementation of its technology.
Source: Reuters.com